Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Frontline”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02984423
What this trial is testing

FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study

Who this might be right for
Ovarian Cancer
AstraZeneca 471
Not applicableStudy completedNCT05113316
What this trial is testing

Mental Health Resources for Frontline Healthcare Workers

Who this might be right for
Mental Health
Emory University 53
Testing effectiveness (Phase 2)WithdrawnNCT04493099
What this trial is testing

Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center
Not applicableStudy completedNCT05540886
What this trial is testing

CLEAN Frontline: A Stepped Wedge Cluster Trial

Who this might be right for
Hospital InfectionsEnvironment, ControlledInfection Control
London School of Hygiene and Tropical Medicine 390
Large-scale testing (Phase 3)Study completedNCT00046683
What this trial is testing

Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia

Who this might be right for
B Cell Chronic Lymphocytic Leukemia
Genzyme, a Sanofi Company 284
Testing effectiveness (Phase 2)UnknownNCT04588194
What this trial is testing

Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaThrombotic Thrombocytopenic Purpura
David Gomez Almaguer 12
Testing effectiveness (Phase 2)Ended earlyNCT01805037
What this trial is testing

Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+114 more
Northwestern University 20
Testing effectiveness (Phase 2)Study completedNCT02520154
What this trial is testing

Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Stage III Fallopian Tube Cancer AJCC v7Stage III Ovarian Cancer AJCC v6 and v7Stage III Primary Peritoneal Cancer AJCC v7+12 more
M.D. Anderson Cancer Center 31
Early research (Phase 1)WithdrawnNCT07052994
What this trial is testing

A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients

Who this might be right for
Pediatric Acute Leukemia
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03617666
What this trial is testing

Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study

Who this might be right for
Hodgkin Lymphoma
University College, London 49
Not applicableStudy completedNCT05107479
What this trial is testing

Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo

Who this might be right for
COVID-19 Vaccine KnowledgeCOVID-19 Vaccine Beliefs
Stanford University 8,959
Testing effectiveness (Phase 2)UnknownNCT05422066
What this trial is testing

Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma

Who this might be right for
DLBCL Germinal Center B-Cell Type
Li Zhiming 50
Not applicableStudy completedNCT05139927
What this trial is testing

Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers

Who this might be right for
COVID-19COVID-19 Testing
New York University 438
Not applicableStudy completedNCT04396600
What this trial is testing

The Professional Peer Resilience Initiative

Who this might be right for
StressStress DisorderStress, Psychological+11 more
University of Minnesota 87
Not applicableStudy completedNCT05899036
What this trial is testing

Early Feasibility Study of RapidPulseTM Aspiration System for Patients With Acute Ischemic Stroke

Who this might be right for
Acute Ischemic StrokeStrokeLarge Vessel Occlusion+1 more
RapidPulse, Inc 19
Not applicableStudy completedNCT05148793
What this trial is testing

N95 Reuse During COVID-19

Who this might be right for
Emergency MedicineFrontline ProvidersHealthcare Worker
University of California, San Francisco 412
Testing effectiveness (Phase 2)Study completedNCT00096018
What this trial is testing

Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04284787
What this trial is testing

BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT06240598
What this trial is testing

Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06974786
What this trial is testing

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly DiagnosedMultiple Myeloma (MM)
SCRI Development Innovations, LLC 100
Next Page
60